Frank Fossella

University of Texas at Houston - MD Anderson Cancer Center

1901 East Road, Unit 1950

Unit 1905

Houston, TX 77030

United States

SCHOLARLY PAPERS

1

DOWNLOADS

23

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Phase II Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemo Naive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905, NCT01064648)

Number of pages: 27 Posted: 09 Oct 2018
University of Texas at Houston - MD Anderson Cancer Center, SWOG Statistical Center, University of Texas at Houston - Department of Translational Molecular Pathology, US Oncology Comprehensive Cancer Centers of Nevada, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Cancer Care Specialists of Illinois, Kaiser Permanente, Montana Cancer Consortium, University of Michigan at Ann Arbor - Medical School, SWOG Statistical Center, University of California, Davis - School of Medicine and University of California, Davis - School of Medicine
Downloads 23 (983,634)
Citation 1

Abstract:

Loading...

mesothelioma, cediranib, cisplatin, pemetrexed, SWOG0905